Also, not only the low expression of KLF5 but the low level of KLF5/high level of BECN1 are associated with the poor prognosis of prostate cancer patients and have a potential value in precision medicine for the prognostic evaluation of patients. Here, BECN1 is linked to prostate carcinoma.